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Edited by Hans EklundAbstract C3-like toxins ADP-ribosylate and inactivate Rho
GTPases. Seven C3-like ADP-ribosyltransferases produced by
Clostridium botulinum, Clostridium limosum, Bacillus cereus
and Staphylococcus aureus were identiﬁed and two representa-
tives – C3bot from C. botulinum and C3stau2 from S. aureus
– were crystallized. Here we present the 1.8 A˚ structure of C.
limosum C3 transferase C3lim and compare it to the structures
of other family members. In contrast to the structure of apo-
C3bot, the canonical ADP-ribosylating turn turn motif is ob-
served in a primed conformation, ready for NAD binding. This
suggests an impact on the binding mode of NAD and on the
transferase reaction. The crystal structure explains why auto-
ADP-ribosylation of C3lim at Arg41 interferes with the ADP-
ribosyltransferase activity of the toxin.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Various bacterial toxins and eﬀectors interfere with eukary-
otic cell functions by ADP-ribosylation of essential cellular
proteins [1–4]. A typical example is the family of C3-like
ADP-ribosyltransferases [5,6]. It comprises the prototype Clos-
tridium botulinum exoenzyme C3bot [7], including the isoforms
C3bot1 and C3bot2, the exoenzyme from Clostridium limosum
(C3lim) [8], Bacillus cereus C3 transferase (C3cer) [9] and three
isoforms of C3stau from Staphylococcus aureus also called
EDIN [10,11].Abbreviations: ARTT-motif, ADP-ribosylation toxin turn turn motif;
C3bot, C3 ADP-ribosyltransferase from Clostridium botulinum; C3cer,
C3 ADP-ribosyltransferase from Bacillus cereus; C3lim, C3
ADP-ribosyltransferase from Clostridium limosum; C3stau2, C3
ADP-ribosyltransferase from Staphylococcus aureus; GST, glutathione
S-transferase
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doi:10.1016/j.febslet.2008.02.051Hallmark of these exoenzymes is the selective N-ADP-ribo-
sylation of the low-molecular mass GTP-binding proteins
RhoA, B and C onto the acceptor amino acid Asn41 [12–14],
resulting in the biological inactivation of signal pathways con-
trolled by Rho GTPases [15]. Consequently, C3-like exoen-
zymes have been valuable pharmacological tools for the
analysis of cellular functions of Rho proteins [5,6]. Whereas
these exoenzymes harbor the enzyme activity, they apparently
miss any speciﬁc cell binding and transportation unit and
therefore, diﬀer from typical AB-toxins, which contain in addi-
tion to the enzyme domain a unit for cell binding and transpor-
tation [5].
C3 transferases are basic 23–25 kDa proteins, which are 30–
77% identical to each other in their amino acid sequences.
Although C3-like ADP-ribosyltransferases share only limited
sequence similarity, key amino acid residues and short peptide
stretches are conserved in all of them. Recently, the crystal
structures of C3bot1 and C3stau2 either unbound or bound
to NAD were reported [16–18], while structures of other family
members have been lacking so far. Together with data derived
from biochemical studies and site-directed mutagenesis [19–
21], the available structure analyses largely improved our
understanding of the mechanism of the ADP-ribosylation
reaction of Rho-ADP-ribosylating transferases. Accordingly,
the active site is delineated on one side by a short loop element,
termed ADP-ribosylating toxin turn turn (ARTT) motif [16].
The ARTT-motif harbors key catalytic residues, a C-termi-
nally located glutamate, termed ‘‘catalytic glutamate’’ and a
glutamine residue two positions upstream (QXE-motif), as
well as a phenylalanine or tyrosine possibly involved in sub-
strate recognition. The ARTT loop is found in many other
ADP-ribosylating toxins, e.g. cholera toxin, pertussis toxin, ac-
tin-modifying C. botulinum C2-toxin and the Pseudomonas
aeruginosa toxins ExoS and ExoT and is suggested to be in-
volved in substrate recognition [16,22,23]. Here we report the
crystal structure at 1.8 A˚ of the C. limosum C3 transferase
and compare it to the structures of other family members.2. Materials and methods
2.1. Protein production
C3lim (residues 1–205) without the N-terminal 45 amino acid signal
sequence (residues 44 to 0) was expressed as a glutathione S-transfer-
ase (GST)-fusion protein. The gene encoding for residues 1–205 of C.
limosum ADP-ribosyltransferase C3lim was cloned into vector pGEX-
2TGL containing a glycine linker cloned with BglII/BamHI sticky ends
into the BamHI site of pGEX-2T. The vector was cut with BamHI andblished by Elsevier B.V. All rights reserved.
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contained an N-terminal GST tag, followed by a thrombin cleavage
site and a 10 amino acid linker before the native C3lim sequence.
Following thrombin cleavage (see below) the artiﬁcially tagged
construct thus contained an N-terminal 12 amino acid extension
(GSPGISGGGGGS).
For expression of recombinant C3lim the protein was overproduced
at 37 C for 10–12 h in the Escherichia coli strain BL21 (Stratagene, La
Jolla, CA) after induction with 0.2 mM isopropyl-D-thiogalactoside.
Cells were harvested by centrifugation, resuspended in lysis buﬀer
(20 mM Tris/HCl (pH 7.5), 10 mM NaCl, 5 mM MgCl2 and 1 mM
PMSF) and broken with a French press (SLM Aminco, Spectronic
Instruments). The lysate was centrifuged for 30 min at 15000 · g.
The supernatant was incubated with glutathione-sepharose beads for
60 min at 4 C to bind the GST-fusion protein. Beads were washed
with buﬀer containing 50 mM Tris/HCl (pH 7.5) and 150 mM NaCl.
The GST-fused C3lim protein was cleaved from the beads with throm-
bin (Sigma) in a buﬀer containing 50 mM TRIS/HCl (pH 7.5), 150 mM
NaCl, 5 mM CaCl2 and 5 mM TEA and further puriﬁed by size exclu-
sion chromatography (Superdex 75, Amersham) in buﬀer-S (20 mM
TRIS/HCl (pH 7.5), 150 mM NaCl, and 5 mM b-mercaptoethanol).
2.2. Crystallization, data collection and processing
Crystals of C3lim were grown at 20 C by sitting drop vapour diﬀu-
sion with drops mixed from 1 lL protein at 10 mg/mL in buﬀer-S and
1lL reservoir solution consisting of 0.2 M ammonium sulfate and 30%
w/v polyethylene glycol 8000. In the cryo-protectant 20% glycerol was
added. Crystals were ﬂash frozen in a 100 K nitrogen stream, after
soaking 5 s in the cryo-protectant. A high resolution data set was col-
lected at 100 K on the PX-1 beamline at the SLS (Villigen, CH). The
diﬀraction data were processed with XDS [24]. Statistics of the data
processing are shown in Table 1.
2.3. Structure determination and reﬁnement
The structure of C3lim was solved with the molecular replacement
method. As search models we used the coordinates of unliganded
C3bot1 (PDB ID 1G24). Calculations were performed with program
Molrep from the CCP4 suite [25] and resulted in unambiguous signals
for two monomers. The model of C3lim was semiautomatically built
with arp–warp [26]. Subsequently missing residues were built using
the program Xﬁt [27] and improved by iterative rounds of manual
rebuilding and reﬁnement with Refmac [28] and Buster (Global Phas-
ing Ltd.). The ﬁnal model has been completed to residues 1–205 of
C3lim, one sulphate ion and 219 water molecules. As deﬁned by PRO-
CHECK there are 92.9 % of residues in the most favored regions of the
Ramachandran plot and 7.1 % in additionally allowed regions. The ﬁ-
nal statistics for the model are listed in Table 1. The program PyMOL
(DeLano Scientiﬁc LLC) was used for ﬁgure preparation and struc-Table 1
Data collection and reﬁnement statistics
Data seta C3lim
Space group P21
Cell dimensions a, b, c (A˚) 40.0, 91.5, 70.9
b () 106.5
Resolution (A˚) 30–1.80 (1.90–1.80)
Observed reﬂections 77583
Unique reﬂections 40980
Completeness (%) 90.4 (72.2)
Rsym




Number of reﬁned atoms 3439
Average B-factor (A˚)b 28.4
Rms deviation
Bond length (A˚) 0.010
Bond angles (A˚) 1.196
aValues in parentheses are for the highest resolution shell.
bRsym = RhklRijIi  ÆIæ j/RhklRiIi.
cRwork = RhkliFobsj  kjFcalci/RhkljFobsj, Rfree was calculated using 5%
of data excluded from reﬁnement.tural analysis (RMSD calculations and distance measurements). Coor-
dinates and structure factors have been deposited in the Protein Data
Bank (PDB ID 3BW8).3. Results and discussion
3.1. Structure determination
Crystals of C3lim grew under several non-redundant condi-
tions (data not shown) with the best crystals obtained in space
group P21 and two molecules in the asymmetric unit (desig-
nated as monomers A and B, respectively). A model of
C3bot1 (with non-conserved residues truncated to alanine)
was used to identify a molecular replacement solution. Elec-
tron density maps, calculated using phases from the molecular
replacement solution showed clear diﬀerence electron density
for side chains of residues that were not included in the search
model. The model of C3lim was reﬁned to a resolution of 1.8 A˚
with an Rfree value of 23.4% and consists of residues 1–205 of
C3lim (Table 1). A representative portion of the ﬁnal electron
density is shown in Fig. 1A. The catalytically important ARTT
loop (see below) has clearly deﬁned electron density in mono-
mer A, whereas residues 169–172 could not be resolved in
monomer B.
3.2. Structure description
The current model covers the entire polypeptide chain of
C3lim, which folds into a mixed a/b-structure ( Fig. 1B) similar
as observed in previously solved structures of ADP-ribosylat-
ing toxins (Fig. 1C and Supplementary Fig. S1). Five a-helices
surround a b-sandwich core, comprising a ﬁve-stranded mixed
b-sheet (b1, b4, b8, b7, b2) and a three-stranded antiparallel b-
sheet (b3, b6, b5). The sheets are aligned in a perpendicular
orientation, causing a cleft in the overall structure, which isFig. 1. Structure of C3lim and comparison with other C3 exoenzymes.
(A) jFoj  jFcj omit map for residues Leu137 to Asn139 of the PN
loop. The electron density is contoured at 3.0 r (green). (B) Ribbon
diagram of C3lim. The catalytic ARTT and PN loops are colored blue
and magenta. Arg41 is shown as a ball-and-stick representation.
Secondary structure elements and N- and C-termini are indicated. (C)
Superimposition of C3lim (backbone trace, color coded as in B) and










Fig. 2. Comparison with other C3 exoenzymes. (A) Stereo view of a structural overlay of the NAD binding pockets of C3lim (grey), C3bot1 (PDB
ID 1G24, chain D, cyan) and C3bot1-NAD (PDB ID 1GZF, chain A, green). Backbone traces are presented as worms. Residues of C3bot1 which
participate in NAD (yellow) interaction are presented as ball and stick model and are labeled in black. Corresponding amino acids of C3lim are
indicated and labeled in grey. (B and C) Comparison of PN- and ARTT loops of C3 toxins. The ARTT loop (blue) and PN loop (magenta) of C3lim
(grey) are superimposed with PN- and ARTT loops of C3bot1 (green) and C3stau2 (orange) in the NAD bound (B) and NAD free (C)
conformations. The analysis is based on the following PDB entries: C3bot1, 1G24, chain D; C3bot1-NAD, 1GZF, chain A; C3stau2, 1OJQ; C3stau2-
NAD, 1OJZ. (D) Sequence alignment of the catalytic ARTT loops (underlined in blue). The numbering refers to C3lim. (E) Stabilization of the
C3lim ARTT loop. The ARTT loop of C3lim (blue) in its NAD free conformational state is stabilized by the side chain of Glu164 which forms polar
interactions (cut-oﬀ level 3.5 A˚, black dotted lines) with main chain amides of residues 171–174. Also indicated is an additional polar contact between
Thr168 and Thr40 of a1. The ARTT loop of C3bot1 in its NAD bound state is superimposed (translucent green). The side chains Asp204C3bot1, and
Ala208C3bot1 (green labels) which are in corresponding positions to Glu164C3lim, and Thr168C3lim (blue labels) are indicated.
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arrangement provides the structural basis of the NAD binding
pocket as shown by the crystal structures of the NAD bound
form of related toxins like C3bot1 and C3stau2, which show
only minor structural diﬀerences to C3lim. Superimposition
of C3lim with the NAD free conformations of C3bot1 (PDB
ID 1G24, chain D) and C3stau2 (PDB ID 1OJQ) reveals low
root mean square deviations (r.m.s.d) of 0.54 and 1.25 A˚,
respectively (Supplementary Fig. S1). Therefore, we assume
an identical NAD binding mode for C3lim. In fact, a structural
overlay of the catalytic core region of C3bot1 bound to NAD
(PDB ID 1GZF, chain A) with the NAD free form of C3lim
reveals that amino acids of C3lim, which correspond to resi-
dues participating in NAD–C3bot1 interaction are almost
identically positioned with an r.m.s.d. of 0.535 A˚ (Fig. 2A
and B). The structural similarity corresponds well to the pri-
mary sequence identities of 61% for C3bot1 and 34% for
C3stau2, respectively. Within the NAD binding region, diﬀer-
ences occur within the PN loop (residues 137–146) and ARTT
loop (residues 166–174), which show slightly diﬀerent confor-
mations. Interestingly, the catalytic ARTT loop of C3lim
(monomer A) adopts a conformation, which resembles the
NAD bound ARTT loop of C3bot1 much more (Fig. 2B) than
its NAD free counterpart (Fig. 2C). A similar observation has
been described for C3stau2 [18] whose ARTT loop conforma-
tion is not dependent on NAD interaction (Fig. 2B and C). In
the latter case a two amino acid insertion ﬂanking the N-termi-
nal ARTT loop region seems to be responsible for the invari-
ant conformation (Fig. 2D). There is no comparable insertion
in C3lim, but a detailed inspection of the ARTT loop reveals a
set of polar interactions which are unique compared to C3bot1
(Fig. 2E). The side chain of Glu164 is suitably arranged to
interact with main chain amides of residues 171–174. The cor-
responding residue in C3bot1 is an aspartate, the side chain of
which is too short to form such a polar network. An additional
interaction is formed between Thr168 and Thr40 of helix a2,
which might also contribute to stabilization of the ARTT loop.
In contrast, in C3bot1 both residues are replaced by alanine.
In summary, the C3lim crystal structure further generalizes
our understanding of C3 toxins and their structure-activity
relationships. Whereas the overall structure is similar to the
known C3 toxins, we observe the ARTT-motif in a unique,
pre-stabilized conformation that resembles C3stau2 more than
C3bot1.3.3. Biochemical implications
The biochemical analysis of C3stau2 identiﬁed the atypical
Rho proteins RhoE/Rnd3 as a unique substrate protein in
addition to RhoA [11]. This modiﬁcation was in part explained
by the ﬁxed conformation and a diﬀerent length of the C3stau2
ARTT loop (Fig. 2D) [11,18]. Structural analysis of C3lim re-
vealed an ARTT loop conformation that is already primed for
NAD binding, similar to apo-C3stau2 but diﬀerent from apo-
C3bot1. Because C3lim does not modify RhoE, it is unlikely
that the ARTT loop conformation found in C3stau2 and
C3lim deﬁne the extended substrate modiﬁcations typical for
C3stau2.
Glu174 of C3lim, which is located at the C-terminal end of
the ARTT loop (Fig. 2A and D), is the so-called ‘‘catalytic glu-
tamic acid’’ residue, which is conserved in all ADP-ribo-
syltransferases studied so far [2,29]. Two amino acid residuesup-stream of the catalytic glutamate is a glutamine residue,
which is conserved in all C3-like exoenzymes forming the
EXQ-motif. This motif is changed to EXE in all known argi-
nine-modifying ADP-ribosyltransferases including for example
the GS-protein-modifying cholera toxin and the actin-modify-
ing binary ADP-ribosylating toxins like C. botulinum C2 toxin
[29]. Recently it has been reported that change of the EXQ-
motif of C3lim to EXE inhibits RhoA ADP-ribosylation at
asparagine but favors modiﬁcation of arginine residues in pol-
yarginine [21]. Moreover, it was shown that EXE-C3lim
(Q172EC3lim) is modiﬁed by intra- and inter-molecular auto-
ADP-ribosylation at arginine residues. The major modiﬁcation
occurs at Arg41C3lim in an intermolecular manner [21]. More
importantly, ADP-ribosylation of C3lim at Arg41 largely re-
duced its activity to ADP-ribosylate RhoA [21]. The crystal
structure of C3lim allows major insights into the role of
Arg41. This residue, which is located in helix 2, is unique in
the group of C3-like transferases. It is located in helix2 at
the connection to helix 3 (Fig. 1B). The crystal structure re-
veals the surface orientation of Arg41C3lim in helix 2. Helix 3
has been suggested to be involved in substrate recognition. De-
duced from the structure of the related Clostridium perfringens
iota toxin, which modiﬁes actin, it has been suggested that
Ser40 and Asn44 in C3stau2 are involved in protein substrate
recognition [18]. Ser40 is equivalent to Ala43 in C3lim and lo-
cated in helix2, whereas Asn44 of C3stau2 is equivalent to
Asn47 in C3lim located in helix3. Also studies on the substrate
speciﬁcity of Pseudomonas exoenzyme S and T reveal that the
region covering the C-terminal part of helix2 and the N-termi-
nal part of helix3, which is directly located at the NAD binding
cleft, form an ‘‘active site loop’’ (from Tyr272-Asn281) crucial
for substrate recognition [30]. Deduced from the structure of
C3lim shown here it is plausible that attachment of ADP-ri-
bose to Arg41C3lim could interfere with toxin-substrate interac-
tions and explain the observed drop in the enzymatic activity.
In conclusion Arg41C3lim represents a potential modulation
site for the enzymatic activity of the transferase and is a unique
characteristic of C3lim.
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